#5 - Herbalife (NYSE:HLF)
In a similar vein to Weight Watchers, Herbalife Ltd. (NYSE: HLF) is an indirect beneficiary of the weight loss drug craze. Weight management is a core piece of the company’s business model. The company offers a range of products including meal replacement products, protein shakes, dietary and nutritional supplements and energy drink products.
HLF stock is up 2.49% after giving up much of the 27% gain it made between May 31 and August 31. The gain was largely due to higher projected sales of its weight management products. Unfortunately, a miss on revenue in its most recent quarter may have investors questioning those claims.
Herbalife analyst ratings on MarketBeat give the stock a Hold rating with a price target of $15.75. That’s low single-digit growth that may not account for expectations of 61% growth in earnings over the next 12 months.
With short interest over 13% and institutional ownership being light, retail investors should approach HLF stock with caution. But with the stock trading below $15 a share, it could offer risk-tolerant investors an opportunity for growth.
About Herbalife
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
Read More - Current Price
- $8.50
- Consensus Rating
- Hold
- Ratings Breakdown
- 2 Buy Ratings, 2 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $9.90 (16.5% Upside)
